| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2015 | MULTIMERIC BIOTHERAPEUTICS, INC. | 5580 LA JOLLA BLVD STE 76 | LA JOLLA | CA | 92037-7651 | SAN DIEGO | USA | R43DK108606 | MagaVax Therapeutic Vaccine for Chronic HBV infection | 000 | 1 | NIH | 2/26/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = -$742 ) |
| | 2017 | 2014 | MULTIMERIC BIOTHERAPEUTICS, INC. | 5580 LA JOLLA BLVD STE 76 | LA JOLLA | CA | 92037-7651 | SAN DIEGO | USA | R43CA180323 | Ovarian cancer therapy using CD40 Ligand (CD40L) | 000 | 1 | NIH | 12/29/2016 | -$742 |
| | 2017 | 2014 | MULTIMERIC BIOTHERAPEUTICS, INC. | 5580 LA JOLLA BLVD STE 76 | LA JOLLA | CA | 92037-7651 | SAN DIEGO | USA | R43AI098246 | Development of a multimeric CD40 ligand vaccine adjuvant | 000 | 2 | NIH | 1/11/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $225,000 ) |
| | 2016 | 2016 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CK000494 | MagaVax vaccine for Ebola | 000 | 1 | CDC | 8/25/2016 | $124,200 |
| | 2016 | 2016 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CK000494 | MagaVax vaccine for Ebola | 002 | 1 | CDC | 9/9/2016 | $100,800 |
| | 2016 | 2016 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CK000494 | MagaVax vaccine for Ebola | 000 | 1 | CDC | 8/25/2016 | $100,800 |
| | 2016 | 2016 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CK000494 | MagaVax vaccine for Ebola | 001 | 1 | CDC | 9/7/2016 | -$124,200 |
| | 2016 | 2016 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CK000494 | MagaVax vaccine for Ebola | 002 | 1 | CDC | 9/9/2016 | $124,200 |
| | 2016 | 2016 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CK000494 | MagaVax vaccine for Ebola | 001 | 1 | CDC | 9/7/2016 | -$100,800 |
|
| Issue Date FY: 2015 ( Subtotal = $223,899 ) |
| | 2015 | 2015 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43DK108606 | MagaVax Therapeutic Vaccine for Chronic HBV infection | 000 | 1 | NIH | 9/23/2015 | $223,899 |
|
| Issue Date FY: 2014 ( Subtotal = $517,300 ) |
| | 2014 | 2014 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43AI098246 | Development of a multimeric CD40 ligand vaccine adjuvant | 000 | 2 | NIH | 7/15/2014 | $293,401 |
| | 2014 | 2014 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43CA180323 | Ovarian cancer therapy using CD40 Ligand (CD40L) | 000 | 1 | NIH | 5/28/2014 | $223,899 |
|
| Issue Date FY: 2013 ( Subtotal = $300,000 ) |
| | 2013 | 2013 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R43AI098246 | Development of a multimeric CD40 ligand vaccine adjuvant | 000 | 1 | NIH | 8/6/2013 | $300,000 |
|
| Issue Date FY: 2011 ( Subtotal = $169,750 ) |
| | 2011 | 2011 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R21DA029435 | PRECISION IMMUNIZATION VACCINE FOR NICOTINE AND OTHER DRUGS OF ABUSE | 000 | 2 | NIH | 5/12/2011 | $169,750 |
|
| Issue Date FY: 2010 ( Subtotal = $175,000 ) |
| | 2010 | 2010 | MULTIMERIC BIOTHERAPEUTICS INC | 5580 LA JOLLA BOULEVARD | LA JOLLA | CA | 92037 | SAN DIEGO | USA | R21DA029435 | PRECISION IMMUNIZATION VACCINE FOR NICOTINE AND OTHER DRUGS OF ABUSE | 000 | 1 | NIH | 5/28/2010 | $175,000 |
|
|
